Pharming (PHAR) Capital Expenditures (2019 - 2023)
Historic Capital Expenditures for Pharming (PHAR) over the last 5 years, with Q2 2023 value amounting to -$986000.0.
- Pharming's Capital Expenditures fell 8925.14% to -$986000.0 in Q2 2023 from the same period last year, while for Jun 2023 it was -$987071.0, marking a year-over-year increase of 7901.61%. This contributed to the annual value of $800000.0 for FY2024, which is 4432.85% down from last year.
- As of Q2 2023, Pharming's Capital Expenditures stood at -$986000.0, which was down 8925.14% from -$208000.0 recorded in Q4 2022.
- Pharming's Capital Expenditures' 5-year high stood at $727929.0 during Q3 2022, with a 5-year trough of -$5.4 million in Q2 2021.
- In the last 5 years, Pharming's Capital Expenditures had a median value of -$459657.2 in 2020 and averaged -$1.1 million.
- In the last 5 years, Pharming's Capital Expenditures tumbled by 4014879.15% in 2021 and then skyrocketed by 13605.5% in 2022.
- Pharming's Capital Expenditures (Quarter) stood at -$2.6 million in 2019, then skyrocketed by 99.81% to -$4859.8 in 2020, then tumbled by 40148.79% to -$2.0 million in 2021, then soared by 89.37% to -$208000.0 in 2022, then plummeted by 374.04% to -$986000.0 in 2023.
- Its Capital Expenditures was -$986000.0 in Q2 2023, compared to -$208000.0 in Q4 2022 and $727929.0 in Q3 2022.